Grant Award View - GA34118
Patient Blood Management Seed Grant:Concealing treatment in pregnancy...
- GA34118-V2 - Delays due to Covid-19 (26-Apr-2023 )
- GA34118-V1 - Ethics and governance approval delays. (12-Jul-2022 )
This study aims to:
1) determine the feasibility and effectiveness of blinding treatment allocation to intravenous (IV) iron or saline placebo infusion using an opaque sleeve covering the syringe and giving set;
2) assess acceptability of blinding/use of placebo intravenous infusions to patients and clinicians, treatment side-effects and adherence, and Health-Related Quality of Life measures in women receiving IV versus oral iron in a blinded, randomised trial; and
3) provide proof-in-principle of ability to effectively blind patients and clinicians to iron deficiency anaemia treatment (IV or oral) received, thereby offering a mechanism to reduce evaluation bias regarding treatment effectiveness in future large-scale clinical trials.